Bevacizumab: In First-Line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma

Author： Frampton James E.   Keating Gillian M.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.22, Iss.2, 2008-01, pp. : 113-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer: Analysis of Multiple Methods

By Li Shaotang  

BioDrugs, Vol. 25, Iss. 1, 2011-02 ,pp. : 43-50

Adis International

Access to resources Recommend Favorite

Pazopanib: In Advanced Renal Cell Carcinoma

By Sanford Mark   Keating Gillian M.  

BioDrugs, Vol. 24, Iss. 5, 2010-10 ,pp. : 279-286

Adis International

Access to resources Recommend Favorite

贝伐单抗在肝癌治疗中的应用现状及进展 Bevacizumab: Current Approach in the Treatment of Hepatocellular Carcinoma

By 钱坤   钱骏  

Medical Diagnosis, Vol. 01, Iss. 01, 2011-09 ,pp. : 1-5

汉斯出版社

Access to resources Recommend Favorite

Cost-effectiveness of anastrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer

By Simons W.R.   Jones D.   Buzdar A.  

Clinical Therapeutics, Vol. 25, Iss. 11, 2003-11 ,pp. : 2972-2987

Elsevier

Access to resources Recommend Favorite

Cutaneous Metastasis of Renal Cell Carcinoma

By Opper Britta   Elsner Peter   Ziemer Mirjana  

American Journal of Clinical Dermatology, Vol. 7, Iss. 4, 2006-01 ,pp. : 271-272

Adis International

Access to resources Recommend Favorite